Couldn’t attend the AD/PD™ 2019 Congress? Our Editor, Sharon Salt, provides her key highlights and takeaway messages from the event.
Browsing: Alzheimer’s disease
Scientists have 3D printed a transparent skull implant for mice, creating a ‘window’ to the brain for monitoring brain surface activity in real time. The implant could provide unique opportunities for research into concussions as well as Alzheimer’s and Parkinson’s diseases.
Researchers have identified adult hippocampal neurogenesis (AHN) in people up to the age of 97 and have noted that ADH gradually declines in people with Alzheimer’s disease.
Biogen and Eisai have announced the decision to discontinue the global Phase III trials of aducanumab for Alzheimer’s disease.
The Medical Research Council (MRC; London, UK) has determined the atomic structures of abnormal tau filaments related to chronic traumatic encephalopathy (CTE) and discovered that the structure is different to tau filaments seen in Alzheimer’s disease.
Results of a recent study indicate that regular consumption of mushrooms may decrease the risk of mild cognitive impairment.
A recently published study has suggested that a noninvasive eye scan may help detect signs of Alzheimer’s disease in a matter of seconds.
The long-term use of hormone-replacement therapy has been linked to a small increased risk of Alzheimer’s disease in postmenopausal women.
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
Much progress has been made on blood-based biomarkers for neurological diseases, though challenges in this field should be addressed before they are applied into clinical use.